Metabolic markers in sports medicine

Advances in Clinical Chemistry

Volumn 56, Issue , 2012, Pages 1-54

  Banfi, Giuseppe ^a,b   Colombini, Alessandra ^a   Lombardi, Giovanni ^a   Lubkowska, Anna ^c,d  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF SZCZECIN   (Poland)

^d POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Aminotransferase; Athletes; Bilirubin; Creatinine; Myoglobin

Indexed keywords

EID: 84855301611     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394317-0.00015-7     Document Type: Chapter

References (167)

1. Hambrecht R., Gielen S. Essay: hunter-gatherer to sedentary lifestyle. Lancet 2005, 366:S60-S61.
2. Astrand P.O. Man as an atlete. Oxford Textbook of Sports Medicine 1998, 3-14. Oxford Medical Publications, Oxford. second ed. M. Harries, C. Williams, W.D. Stanish, L.J. Micheli (Eds.).
3. Fallon K.E. The clinical utility of screening of biochemical parameters in elite athletes: analysis of 100 cases. Br. J. Sports Med. 2008, 42:334-337.
4. Prati D., Taioli E., Zanella A., Della Torre E., Budelli S., Del Vecchio E., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann. Intern. Med. 2002, 137:1-9.
5. Salvaggio A., Periti M., Miano L., Ravanelli L., Marzorati D. Body mass index and liver enzyme activity in serum. Clin. Chem. 1991, 37:720-723.
6. Wejstal R., Hannsson G., Lindholm A., Norkrans G. Persistent alanine aminotransferase elevation in healthy Swedish blood donors mainly caused by obesity. Vox Sang. 1998, 55:152-156.
7. Pappas N.J., Quereshi A.R. Liver aspartate aminotransferase activity as a power function of body weight. Biochem. Med. Metab. 1998, 39:121-125.
8. Banfi G., Morelli P. Relation between body mass index and serum aminotransferases concentrations in professional athletes. J. Sports Med. Phys. Fitness 2008, 48:197-200.
9. Lee H., Park J.E., Choi I., Cho K.H. Enhanced functional and structural properties of high-density lipoproteins from runners and wrestlers compared to throwers and lifters. BMB Rep. 2009, 42:605-610.
10. Kratz A., Lewandrowski K.B., Siegel A.J., Chun K.Y., Flood J.G., van Cott E.M., et al. Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am. J. Clin. Pathol. 2002, 118:856-863.
11. Nagel D., Seiler D., Franz H., Jung K. Ultralong distance running and the liver. Int. J. Sports Med. 1990, 11:441-445.
12. Saengsirisuwan V., Phadungkij S., Pholpramool C. Renal and liver functions and muscle injuries during training and after competition in Thai boxers. Br. J. Sports Med. 1998, 32:304-308.
13. Selden M.A., Helzberg J.H., Waeckerle J.F., Browne J.E., Brewer J.H., Monaco M.E., et al. Elevated alanine aminotransferase in current national football league players: correlation with cardiometabolic syndrome markers, obesity, and insulin resistance. South. Med. J. 2009, 102:1003-1006.
14. Hoffman J.R., Kang J., Ratamess N.A., Faigenbaum A.D. Biochemical and hormonal responses during an intercollegiate football season. Med. Sci. Sports Exerc. 2005, 37:1237-1241.
15. Maddali S., Rodeo S.A., Barnes R., Warren R.F., Murrell G.A.C. Postexercise increase in nitric oxide in football players with muscle cramps. Am. J. Sports Med. 1998, 26:820-824.
16. Deugnier Y., Loréal O., Carré F., Duvallet A., Zoulim F., Vinel J.P., et al. Increased body iron stores in elite road cyclists. Med. Sci. Sports Exerc. 2002, 34:876-880.
17. Urhausen A., Torsten A., Wilfried K. Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers. J. Steroid Biochem. Mol. Biol. 2003, 84:369-375.
18. Nieminen M.S., Rämö M.P., Viitasalo M., Heikkila P., Karjalainen J., Mantysaari M. Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters. Eur. Heart J. 1996, 17:1576-1583.
19. Telford R.D., Sly G.J., Hahn A.G., Cunningham R.B., Bryant C., Smith J.A. Footstrike is the major cause of hemolysis during running. J. Appl. Physiol. 2003, 94:38-42.
20. Miller B.J., Pate R.R., Burgess W. Foot impact force and intravascular hemolysis during distance running. Int. J. Sports Med. 1988, 9:56-60.
21. Fallon K.E., Sivyer G., Sivyer K., Dare A. The biochemistry of runners in a 1600 km ultramarathon. Br. J. Sports Med. 1999, 33:264-269.
22. Wade C.E., Hill L.C., Hunt M.M., Dressendorfer R.H. Plasma aldosterone and renal function during a 20 day road race. Eur. J. Appl. Physiol. 1985, 54:456-460.
23. Schulpis K.H., Tsironi M., Skenderi K., Lazaropoulou C., Parthimos N., Reclos G., et al. Dramatic reduction of erythrocyte glucose-6-phosphate dehydrogenase activity in athletes participating in the ultradistance foot race "Spartathlon". Scand. J. Clin. Lab. Invest. 2008, 68:228-232.
24. Reinke S., Karhausen T., Doehner W., Taylor W., Hottenrott K., Duda G.N., et al. The influence of recovery and training phases on body composition, peripheral vascular function and immune system of professional soccer players. PLoS One 2009, 4:e4910.
25. Cazzola R., Russo-Volpe S., Cervato G., Cestaro B. Biochemical assessment of oxidative stress, erythrocyte membrane fluidity and antioxidant status in professional soccer players and sedentary controls. Eur. J. Clin. Invest. 2003, 33:924-930.
26. Banfi G., Di Gaetano N., Lopez R.M., Melegati G. Decreased mean sphered cell volume values in top-level rugby players are related to the intravascular hemolysis induced by exercise. Lab. Hematol. 2007, 13:103-107.
27. Warren J.D., Blumbergs P.C., Thompson P.D. Rhabdomyolysis: a review. Muscle Nerve 2002, 25:332-347.
28. Skenderi K.P., Kavouras S.A., Anastasiou C.A., Yiannakouris N., Matalas A. Exertional rabdomyolysis during a 246-km continuous running race. Med. Sci. Sports Exerc. 2006, 38:1054-1107.
29. Brancaccio P., Maffulli N., Limongelli F.M. Creatine kinase monitoring in sport medicine. Br. Med. Bull. 2007, 81-82:209-230.
30. Clarkson P.M., Hubal M.J. Exercise-induced muscle damage in humans. Am. J. Phys. Med. Rehabil. 2002, 81:S52-S69.
31. Vincent H.K., Vincent K.R. The effect of training status on the serum creatine kinase response, soreness and muscle function following resistance exercise. Int. J. Sports Med. 1997, 18:431-437.
32. Saraslanidis P.J., Manetzis C.G., Tsalis G.A., Zafeiridis A.S., Mougios V.G., Kellis S.E. Biochemical evaluation of running workouts used in training for the 400-m sprint. J. Strength Cond. Res. 2009, 23:2266-2271.
33. Yamamoto L.M., Judelson D.A., Farrell M.J., Lee E.C., Armstrong L.E., Casa D.J., et al. Effects of hydration state and resistance exercise on markers of muscle damage. J. Strength Cond. Res. 2008, 22:1387-1393.
34. Lippi G., Brocco G., Salvagno G.L., Montagnana M., Dima F., Guidi G.C. High-workload endurance training may increase serum ischemia-modified albumin concentrations. Clin. Chem. Lab. Med. 2005, 43:741-744.
35. Lippi G., Banfi G. Distribution of creatine kinase in sedentary and physically active individuals. Am. Heart J. 2008, 155:e51.
36. Coutts A.J., Reaburn P., Piva T.J., Rowsell G.J. Monitoring for overreaching in rugby league players. Eur. J. Appl. Physiol. 2007, 99:313-324.
37. Halson S.L., Bridge M.W., Meeusen R., Busschaert B., Gleeson M., Jones D.A., et al. Time course of performance changes and fatigue markers during intensified training in cyclists. J. Appl. Physiol. 2002, 93:947-956.
38. Margaritis I., Tessier F., Verdera F., Bermon S., Marconnet P. Muscle enzyme release does not predict muscle function impairment after triathlon. J. Sports Med. Phys. Fitness 1999, 39:133-139.
39. Mougios V. Reference intervals for serum creatine kinase in athletes. Br. J. Sports Med. 2007, 41:674-678.
40. Cunniffe B., Hore A.J., Whitcombe D.M., Jones K.P., Baker B.J., Davies B. Time course of changes in immuneoendocrine markers following an international rugby game. Eur. J. Appl. Physiol. 2010, 108:113-122.
41. Takarada Y. Evaluation of muscle damage after a rugby match with special reference to tackle plays. Br. J. Sports Med. 2003, 37:416-419.
42. Zuliani U., Bonetti A., Franchini D., Serventi G., Ugolotti G., Varacca A. Effect of boxing on some metabolic indices of muscular contraction. Int. J. Sports Med. 1985, 6:234-236.
43. Gill N.D., Beaven C.M., Cook C. Effectiveness of post-match recovery strategies in rugby players. Br. J. Sports Med. 2006, 40:260-263.
44. Banfi G., Melegati G., Valentini P. Effects of cold water immersion of legs after training session on serum creatine kinase concentrations in rugby players. Br. J. Sports Med. 2007, 41:339.
45. Sellwood K.S., Brukner P., Williams D., Nicol A., Hinman R. Ice-water immersion and delayed-onset muscle soreness: a randomised controlled trial. Br. J. Sports Med. 2007, 41:392-397.
46. Vaile J., Halson S., Gill N., Dawson B. Effect of hydrotherapy on the signs and symptoms of delayed onset muscle soreness. Eur. J. Appl. Physiol. 2008, 102:447-455.
47. Brancaccio P., Limongelli F.M., Maffulli N. Monitoring of serum enzymes in sport. Br. J. Sports Med. 2006, 40:96-97.
48. Smith J.E., Garbutt G., Lopes P., Pedoe D.T. Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department. Br. J. Sports Med. 2004, 38:292-294.
49. Lippi G., Salvagno G.L., Montagnana M. Influence of physical exercise and relationship with biochemical variables of NT-pro brain natriuretic peptide and ischemia modified albumin. Clin. Chim. Acta 2006, 367:175-180.
50. Priest J.B., Oei T.O., Moorehead W.R. Exercise-induced changes in common laboratory tests. Am. J. Clin. Pathol. 1982, 77:285-289.
51. Munjal D.D., McFadden J.A., Matix P.A., Coffman K.D., Cattaneo S.M. Changes in serum myoglobin, total creatine kinase, lactate dehydrogenase and creatine kinase MB levels in runners. Clin. Biochem. 1983, 16:195-199.
52. Lippi G., Schena F., Salvagno G.L., Montagnana M., Gelati M., Tarperi C., et al. Acute variation of biochemical markers of muscle damage following a 21-km, half-marathon run. Scand. J. Clin. Lab. Invest. 2008, 68:667-672.
53. König D., Schumacher Y.O., Heinrich L., Schmid A., Berg A., Dickhuth H.H. Myocardial stress after competitive exercise in professional road cyclists. Med. Sci. Sports Exerc. 2003, 35:1679-1683.
54. Neilan T.G., Jannuzzi J.L., Lee-Lewandrowski E., Ton-Nu T.T., Yoerger D.M., Jassal D.S., et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston Marathon. Circulation 2006, 114:2325-2333.
55. Scharhag J., Urhausen A., Schneider G., Herrmann M., Schumacher K., Haschke M., et al. Reproducibility and clinical significance of exercise-induced increases in cardiac troponins and N-terminal pro brain natriuretic peptide in endurance athletes. Eur. J. Cardiovasc. Prev. Rehabil. 2006, 13:388-397.
56. Scharhag J., Urhausen A., Herrmann M., Schneider G., Kramann B., Herrmann W., et al. No difference in N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations between endurance athletes with athlete's heart and healthy untrained controls. Heart 2004, 90:1055-1056.
57. Banfi G., Lippi G., Susta D., Barassi A., Melzi d'Eril G., Dogliotti G., et al. NT-proBNP concentrations in mountain marathoners. J. Strength Cond. Res. 2010, 24:1369-1372.
58. Tchou I., Margeli A., Tsironi M., Skenederi K., Barnet M., Kanaka-Gantenbein C., et al. Growth-differentiation-factor-15, endoglin and N-terminal pro-brain natriuretic peptide induction in athletes participating in an ultramarathon foot race. Biomarkers 2009, 14:418-422.
59. Scott J.M., Esch B.T., Shave R., Warburton D.E., Gaze D., George K. Cardiovascular consequences of completing a 160-km ultramarathon. Med. Sci. Sports Exerc. 2009, 41:26-34.
60. Frassl W., Kowoll R., Katz N., Speth M., Stangl A., Brechtel L., et al. Cardiac markers (BNP, NT-proBNP, troponin I, troponin T) in female amateur runners before and up until three days after a marathon. Clin. Lab. 2008, 54:81-87.
61. Leers M.P.G., Schepers R., Baumgarten R. Effects of a long-distance run on cardiac markers in healthy athletes. Clin. Chem. Lab. Med. 2006, 44:999-1003.
62. Neumayr G., Pfister R., Mitterbauer G., Eibl G., Hoertnagl H. Effect of competitive marathon cycling on plasma N-Terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists. Am. J. Cardiol. 2005, 96:732-735.
63. Knebel F., Schimke I., Schroeckh S., Peters H., Eddicks S., Schattke S., et al. Myocardial function in older male amateur marathon runners: assessment by tissue Doppler echocardiography, speckle tracking, and cardiac biomarkers. J. Am. Soc. Echocardiogr. 2009, 22:803-809.
64. Godon P., Griffet V., Vinsonneau U., Caignault J.R., Prevosto J.M., Quiniou G., et al. Athlete's heart or hypertrophic cardiomyopathy: usefulness of N-terminal pro-brain natriuretic peptide. Int. J. Cardiol. 2009, 137:72-74.
65. Lowbeer C., Seeberger A., Gustafsson S.A., Bouvier F., Hulting J. Serum cardiac troponin T, troponin I, plasma BNP and left ventricular mass index in professional football players. J. Sci. Med. Sport 2007, 10:291-296.
66. Banfi G., Melzi d'Eril G., Barassi A., Lippi G. NT-proBNP concentrations in elite rugby players at rest and after active and passive recovery following strenuous training sessions. Clin. Chem. Lab. Med. 2008, 46:247-249.
67. Banfi G., Migliorini S., Dolci A. B-type natriuretic peptide in athletes performing an Olympic triathlon. J. Sports Med. Phys. Fitness 2005, 45:529-531.
68. Pagourelias E.D., Giannoglou G., Kouidi E., Efthimiadis G.K., Zorou P., Tziomalos K., et al. Brain natriuretic peptide and the athlete's heart: a pilot study. Int. J. Clin. Pract. 2010, 64:511-517.
69. O'Hanlon R., Wilson M., Wage R., Smith G., Alpendurada F.D., Wong J., et al. Troponin release following endurance exercise: is inflammation the cause? a cardiovascular magnetic resonance study. J. Cardiovasc. Magn. Res. 2010, 12:38-44.
70. Scharhag J., George K., Shave R., Urhausen A., Kindermann W. Exercise-associated increases in cardiac biomarkers. Med. Sci. Sports Exerc. 2008, 40:1408-1415.
71. Montgomery H., Clarkson P., Dollery C., Prasad K., Losi M.A., Hemingway H., et al. Association of angioetensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997, 96:741-747.
72. Bernstein L.H., Zions M.Y., Haq S.A., Zarich S., Rucinski J., Seamonds B., et al. Effect of renal function loss on NT-proBNP level variations. Clin. Biochem. 2009, 42:1091-1098.
73. Lippi G., Cervellin G., Plebani M. Sensitive cardiac troponin T assay. N. Engl. J. Med. 2010, 362:1242.
74. Roth H.J., Leithäuser R.M., Doppelmayr H., Doppelmayr M., Finkernagel H., von Duvillard S.P., et al. Cardiospecificity of the 3rd generation cardiac troponin T assay during and after a 216 km ultra-endurance marathon run in Death Valley. Clin. Res. Cardiol. 2007, 96:359-364.
75. Fortescue E.B., Shin A.Y., Greenes D.S., Mannix R.C., Agarwal S., Feldman B.J., et al. Cardiac troponin increases among runners in the Boston Marathon. Ann. Emerg. Med. 2007, 49:137-143.
76. Lippi G., Schena F., Salvagno G.L., Montagnana M., Gelati M., Tarperi C., et al. Influence of a half-marathon run on NT-proBNP and troponin T. Clin. Lab. 2008, 54:251-254.
77. Middleton N., George K., Whyte G., Gaze D., Collinson P., Shave R. Cardiac troponin T release is stimulated by endurance exercise in healthy humans. J. Am. Coll. Cardiol. 2008, 52:1813-1814.
78. Mingels A., Jacobs L., Michielsen E., Swaanenburg J., Wodzig W., van Dieijen-Visser M. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin. Chem. 2009, 55:101-108.
79. Jassal D.S., Moffat D., Krahn J., Ahmadie R., Fang T., Eschun G., et al. Cardiac injury markers in non-elite marathon runners. Int. J. Sports Med. 2009, 30:75-79.
80. Fu F., Nie J., Tong T.K. Serum cardiac troponin T in adolescent runners: effects of exercise intensity and duration. Int. J. Sports Med. 2009, 30:168-172.
81. Hubble K.M., Fatovich D.M., Grasko J.M., Vasikaran S.D. Cardiac troponin increases among marathon runners in the Perth Marathon: the Troponin in Marathons (TRIM) study. Med. J. Aust. 2009, 190:91-93.
82. Giannitsis E., Roth H.J., Leithäuser R.M., Scherhag J., Beneke R., Katus H.A. New highly sensitivity assay used to measure cardiac troponin T concentration changes during a continuous 216-km marathon. Clin. Chem. 2009, 55:590-592.
83. Mousavi N., Czarnecki A., Kumar K., Fallah-Rad N., Lytwyn M., Han S.Y., et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am. J. Cardiol. 2009, 103:1467-1472.
84. Serrano-Ostáriz E., Legaz-Arrese A., Terreros-Blanco J.L., López-Ramón M., Cremades-Arroyos D., Carranza-García L.E., et al. Cardiac biomarkers and exercise duration and intensity during a cycle-touring event. Clin. J. Sport Med. 2009, 19:293-299.
85. Sahlén A., Gustafsson T.P., Svensson J.E., Marklund T., Winter R., Linde C., et al. Predisposing factors and consequences of elevated biomarker levels in long-distance runners aged >or=55 years. Am. J. Cardiol. 2009, 104:1434-1440.
86. Serrano-Ostáriz E., Terreros-Blanco J.L., Legaz-Arrese A., George K., Shave R., Bocos-Terraz P., et al. The impact of exercise duration and intensity on the release of cardiac biomarkers. Scand. J. Med. Sci. Sports 2011, 21:244-249.
87. Regwan S., Hulten E.A., Martinho S., Slim J., Villines T.C., Mitchell J., et al. Marathon running as a cause of troponin elevation: a systematic review and meta-analysis. J. Interv. Cardiol. 2010, 23:443-450.
88. Lippi G., Plebani M. High-sensitive troponin testing and the " runner's syndrome" J. Emerg. Med. 2009, 41:85-87.
89. Lippi G., Banfi G. Exercise-related increase of cardiac troponin release in sports: an apparent paradox finally elucidated?. Clin. Chim. Acta 2010, 410:610-611.
90. Hickman P.E., Potter J.M., Aroney C., Koerbin G., Southcott E., Wu A.H., et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin. Chim. Acta 2009, 411:318-323.
91. Myers G.L., Miller W.G., Coresh J., Fleming J., Greenberg N., Greene T., et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin. Chem. 2006, 52:5-18.
92. Banfi G., Del Fabbro M., Lippi G. Serum creatinine concentration and creatinine-based estimation of glomerular filtration rate in athletes. Sports Med. 2009, 39:331-337.
93. Banfi G., Del Fabbro M. Serum creatinine values in elite athletes competing in 8 different sports: comparison with sedentary people. Clin. Chem. 2006, 52:330-331.
94. Lippi G., Brocco G., Franchini M., Schena F., Guidi G.C. Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls. Clin. Chem. Lab. Med. 2004, 42:644-647.
95. Lippi G., Salvagno G.L., Montagnana M., Schena F., Ballestreri F., Guidi G.C. Influence of physical exercise and relationship with biochemical variables of NT-pro-brain natriuretic peptide and ischemia modified albumin. Clin. Chim. Acta 2006, 367:175-180.
96. Reid S.A., Speedy D.B., Thompson J.M.D., Noakes T.D., Mulligan G., Page T., et al. Study of haematological and biochemical parameters in runners competing a standard marathon. Clin. J. Sport Med. 2004, 14:344-353.
97. Neumayr G., Pfister R., Hoertnagl H., Mitterbauer G., Prokop W., Joannidis M. Renal function and plasma volume following ultramarathon cycling. Int. J. Sports Med. 2005, 26:2-8.
98. Banfi G., Del Fabbro M., Lippi G. Creatinine values during a competitive season in elite athletes involved in different sport disciplines. J. Sports Med. Phys. Fitness 2008, 48:479-482.
99. Lippi G., Banfi G., Salvagno G.L., Franchini M., Guidi G.C. Glomerular filtration rate in endurance athletes. Clin. J. Sports Med. 2008, 18:286-288.
100. Lippi G., Banfi G., Salvagno G.L., Montagnana M., Franchini M., Guidi G.C. Comparison of creatinine-based estimations of glomerular filtration rate in endurance athletes at rest. Clin. Chem. Lab. Med. 2008, 46:235-239.
101. Lippi G., Schena F., Salvagno G.L., Tarperi C., Montagnana M., Gelati M., et al. Acute variation of estimated glomerular filtration rate following a half-marathon run. Int. J. Sports Med. 2008, 29:948-951.
102. Mingels A., Jacobs L., Kleijnen V., Wodzig W., Dieijen-Visser M. Cystatin C a marker for renal function after exercise. Int. J. Sports Med. 2009, 30:668-671.
103. Banfi G., Del Fabbro M., Melzi d'Eril G., Melegati G. Reliability of cystatin C in estimating renal function in rugby players. Ann. Clin. Biochem. 2009, 46:428.
104. Pichler J., Risch L., Hefti U., Merz T.M., Turk A.J., Bloch K.E., et al. Glomerular filtration rate estimates decrease during high altitude expedition but increase with Lake Louise acute mountain sickness scores. Acta Physiol. 2008, 192:443-450.
105. Lippi G., Montagnana M., Franchini M., Favaloro E.J., Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin. Chim. Acta 2008, 392:1-7.
106. Zieliński J., Rychlewski T., Kusy K., Domaszewska K., Laurentowska M. The effect of endurance training on changes in purine metabolism: a longitudinal study of competitive long-distance runners. Eur. J. Appl. Physiol. 2009, 106:867-876.
107. Sjodin B., Helsten Westing Y. Changes in plasma concentrations of hypoxanthine and uric acid in man with short distance running at various intensities. Int. J. Sports Med. 1990, 11:485-495.
108. Sahlin K., Tonkonogi M., Söderlund K. Plasma hypoxanthine and ammonia in humans during prolonged exercise. Eur. J. Appl. Physiol. Occup. Physiol. 1999, 80:417-422.
109. Finaud J., Scilowski V., Lac G., Durand D., Vidalin H., Robert A., et al. Antioxidant status and oxidative stress in professional rugby players: evolution throughout a season. Int. J. Sports Med. 2006, 27:87-93.
110. Teixeira V., Valente H., Casal S., Pereira L., Marques F., Moreira P. Antoxidant status, oxidative stress, and damage in elite kayakers after 1 year of training and competition in 2 seasons. Appl. Physiol. Nutr. Metab. 2009, 34:716-724.
111. Lombardi G., Colombini A., Ricci C., Freschi M., Lippi G., Banfi G. Serum uric acid in top-level alpine skiers over four consecutive competitive seasons. Clin. Chim. Acta 2010, 411:645-648.
112. O'Reilly J., Wong S.H., Chen Y. Glycaemic index, glycaemic load and exercise performance. Sports Med. 2010, 40:27-39.
113. Christ-Roberts C.Y., Pratipanawatr T., Pratipanawatr W., Berria R., Belfort R., Mandarino L.J. Increased insulin receptor signaling and glycogen synthase activity contribute to the synergistic effect of exercise on insulin action. J. Appl. Physiol. 2003, 95:2519-2529.
114. Carter S.L., Rennie C., Tarnopolsky M.A. Substrate utilization during endurance exercise in men and women after endurance training. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E898-E907.
115. Frøsig C., Richter E.A. Improved insulin sensitivity after exercise: focus on insulin signaling. Obesity 2009, 17(Suppl. 3):S15-S20.
116. Lippi G., Montagnana M., Salvagno G.L., Franchini M., Guidi G.C. Glycaemic control in athletes. Int. J. Sports Med. 2008, 29:7-10.
117. Buell J.L., Calland D., Hanks F., Johnston B., Pester B., Sweeney R., et al. Presence of metabolic syndrome in football linemen. J. Athl. Train. 2008, 43:608-616.
118. Viru A. Plasma hormones and physical exercise. Int. J. Sports Med. 1992, 13:201-209.
119. Viru A., Karelson K., Smirnova T. Stability and variability in hormonal responses to prolonged exercise. Int. J. Sports Med. 1992, 13:230-235.
120. Rowlands D.S., Wadsworth D.P. Effect of high-protein feeding on performance and nitrogen balance in female cyclists. Med. Sci. Sports Exerc. 2011, 43:44-53.
121. Chou S.W., Lai C.H., Hsu T.H., Cho Y.M., Ho H.Y., Lai Y.C., et al. Characteristics of glycemic control in power and endurance athletes. Prev. Med. 2005, 40:564-569.
122. Kujala U.M., Sarna S., Kaprio J. Use of medications and dietary supplements in later years among former top-level athletes. Ann. Intern. Med. 2003, 12:1064-1068.
123. Kraus W.E., Houmard J.A., Duscha B.D., Knetzger K.J., Wharton M.B., McCartney J.S., et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med. 2002, 347:1483-1492.
124. Blair S.N., Lamonte M.J., Nichaman M.Z. The evolution of physical activity recommendations: how much is enough?. Am. J. Clin. Nutr. 2004, 79:913S-920S.
125. Lippi G., Schena F., Salvagno G.L., Montagnana M., Ballestrieri F., Guidi G.C. Comparison of the lipid profile and lipoprotein(a) between sedentary and highly trained subjects. Clin. Chem. Lab. Med. 2006, 44:322-326.
126. Aguiló A., Tauler P., Guix M.P., Villa G., Cordova A., Tur J.A., et al. Effect of exercise intensity and training on antioxidants and cholesterol profile in cyclists. J. Nutr. Biochem. 2003, 14:319-325.
127. Petridou A., Lazaridou D., Mougios V. Lipidemic profile of athletes and non-athletes with similar body fat. Int. J. Sport Nutr. Exerc. Metab. 2005, 15:425-432.
128. Cardoso G.C., Posadas C., Orvanaños O.O., Penich C., Zamora J., Aguilar R., et al. Long distance runners and body-builders exhibit elevated plasma levels of lipoprotein(a). Chem. Phys. Lipids 1994, 67/68:207-221.
129. Eisenmann J.C., Womack C.J., Reeves M.J., Pivarnik J.M., Malina R.M. Blood lipids in young distance runners. Med. Sci. Sports Exerc. 2001, 33:1661-1666.
130. Guerra A., Rego C., Laires M.J., Castro E.M., Silva D., Monteiro C., et al. Lipid profile and redox status in high performance rhythmic female teenagers gymnasts. J. Sports Med. Phys. Fitness 2001, 41:505-512.
131. Rickenlund A., Eriksson M.J., Schenck-Gustafsson K., Hirschberg A.L. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile. J. Clin. Endocrinol. Metab. 2005, 90:1354-1359.
132. Di Santolo M., Banfi G., Stel G., Cauci S. Association of recreational physical activity with homocysteine, folate and lipid markers in young women. Eur. J. Appl. Physiol. 2008, 105:111-118.
133. Keul J., Kohler B., von Glutz G., Luthi U., Berg A., Howald H. Biochemical changes in a 100 km run: carbohydrates, lipids and hormones in serum. Eur. J. Appl. Physiol. 1981, 47:181-189.
134. Saravia S.G., Knebel F., Schroeckh S., Ziebig R., Lun A., Weimann A., et al. Cardiac troponin T release and inflammation demonstrated in marathon runners. Clin. Lab. 2010, 56:51-58.
135. Lehmann M., Dickhuth H.H., Gendrisch G., Lazar W., Thum M., Kaminski R., et al. Training-overtraining. A prospective, experimental study with experienced middle- and long-distance runners. Int. J. Sports Med. 1991, 12:444-452.
136. Ginsburg G.S., Agil A., O'Toole M., Rimm E., Douglas P.S., Riafi N. Effects of a single bout of ultraendurance exercise on lipid levels and susceptibility of lipid to peroxidation in triathletes. JAMA 1996, 276:221-225.
137. Margeli A., Skenderi K., Tsironi M., Hantzi E., Matalas A.L., Vrettou C., et al. Dramatic elevations of interleukin-6 and acute-phase reactants in athletes participating in the ultradistance foot race spartathlon: severe systemic inflammation and lipid and lipoprotein changes in protracted exercise. J. Clin. Endocrinol. Metab. 2005, 90:3914-3918.
138. Pialoux V., Mounier R., Rock E., Mazur A., Schmitt L., Richalet J.P., et al. Effects of the 'live high-train low' method on prooxidant/antioxidant balance on elite athletes. Eur. J. Clin. Nutr. 2009, 63:756-762.
139. Hernández-Torres R.P., Ramos-Jiménez A., Torres-Durán P.V., Romero-Gonzalez J., Mascher D., Posadas-Romero C., et al. Effects of single sessions of low-intensity continuous and moderate-intensity intermittent exercise on blood lipids in the same endurance runners. J. Sci. Med. Sport 2009, 12:323-331.
140. Mengelkoch L.J., Pollock M.L., Limacher M.C., Graves J.E., Shireman R.B., Riley W.J., et al. Effects of age, physical training, and physical fitness on coronary heart disease risk factors in older track athletes at twenty-year follow-up. J. Am. Geriatr. Soc. 1997, 45:1446-1453.
141. Lynch N.A., Ryan A.S., Evans J., Katzel L.I., Goldberg A.P. Older elite football players have reduced cardiac and osteoporosis risk factors. Med. Sci. Sports Exerc. 2007, 39:1124-1130.
142. Petibois C., Cassaigne A., Gin H., Déléris G. Lipid profile disorders induced by long-term cessation of physical activity inpreviously highly endurance-trained subjects. J. Clin. Endocrinol. Metab. 2004, 89:3377-3384.
143. Real J.T., Merchante A., Gómez J.L., Chaves F.J., Ascaso J.F., Carmena R. Effects of marathon running on plasma total homocysteine concentrations. Nutr. Metab. Cardiovasc. Dis. 2005, 15:134-139.
144. Borrione P., Rizzo M., Spaccamiglio A., Salvo R.A., Dovio A., Termine A., et al. Sport-related hyperhomocysteinaemia: a putative marker of muscular demand to be noted for cardiovascular risk. Br. J. Sports Med. 2008, 42:894-900.
145. Unt E., Zilmer K., Magi A., Kullisaar T., Kairane C., Zilmer M. Homocysteine status in former top-level male athletes: possible effect of physical activity and physical fitness. Scand. J. Med. Sci. Sports 2008, 18:360-366.
146. Banfi G., Lombardi G., Colombini A., Lippi G. Bone metabolism markers in sports medicine. Sports Med. 2010, 40:697-714.
147. Maïmoun L., Sultan C. Effects of physical activity on bone remodeling. Metabolism 2011, 60:373-388.
148. Nishiyama S., Tomoeda S., Ohta T., Higuchi A., Matsuda I. Differences in basal and postexercise osteocalcin levels in athletic and nonathletic humans. Calcif. Tissue Int. 1988, 49:373-377.
149. Malm H., Ronni-Sivula H.M., Viinika L.U., Ylikorkala O.L. Marathon running accompanied by transient decreases in urinary calcium and serum osteocalcin levels. Calcif. Tissue Int. 1993, 52:209-211.
150. Kristoffersson A., Hultdin J., Holmlund I., Thorsen K., Lorentzon R. Effects of short term maximal work on plasma calcium, parathyroid hormone, osteocalcin and biochemical markers of collagen metabolism. Int. J. Sports Med. 1995, 16:145-149.
151. Brahm H., Piehl-Aulin K., Ljunghall S. Biochemical markers of bone metabolism during distance running in healthy, regularly exercising men and women. Scand. J. Med. Sci. Sports 1996, 6:26-30.
152. Langberg H., Skovgaard D., Asp S., Kjaer M. Time pattern of exercise-induced changes in type I collagen turnover after prolonged endurance exercise in humans. Calcif. Tissue Int. 2000, 67:41-44.
153. Guillemant J., Accarie C., Peres G., Guillemant S. Acute effects of an oral calcium load on markers of bone metabolism during endurance cycling exercise in male athletes. Calcif. Tissue Int. 2004, 74:407-414.
154. Maïmoun L., Galy O., Manetta J., Coste O., Peruchon E., Micallef J.P., et al. Competitive season of triathlon does not alter bone metabolism and bone mineral status in male triathletes. Int. J. Sports Med. 2004, 25:230-234.
155. Jürimäe J., Purge P., Jürimäe T., von Duvillard S.P. Bone metabolism in elite male rowers: adaptation to volume-extended training. Eur. J. Appl. Physiol. 2006, 97:127-132.
156. Herrmann M., Muller M., Scharhag J., Sand-Hill M., Kindermann W., Herrmann W. The effect of endurance exercise-induced lactacidosis on biochemical markers of bone turnover. Clin. Chem. Lab. Med. 2007, 45:1381-1389.
157. Mouzopoulos G., Stamatakos M., Tzurbakis M., Tsembeli A., Manti C., Safioleas M., et al. Changes of bone turnover markers after marathon running over 245 km. Int. J. Sports Med. 2007, 28:576-579.
158. Lippi G., Schena F., Montagnana M., Salvagno G.L., Banfi G., Guidi G.C. Acute variation of osteocalcin and parathyroid hormone in athletes after running a half-marathon. Clin. Chem. 2008, 54:1093-1095.
159. Rector R.S., Rogers R., Ruebel M., Widzer M.O., Hinton P.S. Lean body mass and weight-bearing activity in the prediction of bone mineral density in physically active men. J. Strength Cond. Res. 2009, 23:427-435.
160. Bennell K.L., Malcolm S.A., Khan K.M., Thomas S.A., Reid S.J., Brukner P.D., et al. Bone mass and bone turnover in power athletes, endurance athletes, and controls: a 12-month longitudinal study. Bone 1997, 20:477-484.
161. O'Kane J.W., Hutchinson E., Atley L.M., Eyre D.R. Sport-related differences in biomarkers of bone resorption and cartilage degradation in endurance athletes. Osteoarthr. Cartil. 2006, 14:71-76.
162. Iwamoto J., Takeda T., Uenishi K., Ishida H., Sato Y., Matsumoto H. Urinary levels of cross-linked N-terminal telopeptide of type I collagen and nutritional status in Japanese professional baseball players. J. Bone Miner. Metab. 2010, 28:540-546.
163. Creighton D.L., Morgan A.L., Boardley D., Brolinson P.G. Weight bearing exercise and markers of bone turnover in female athletes. J. Appl. Physiol. 2001, 90:565-570.
164. Karlsson K.M., Karlsson C., Ahlborg H.G., Valdimarsson O., Ljunghall S. The duration of exercise as a regulator of bone turnover. Calcif. Tissue Int. 2003, 73:350-355.
165. Ryan A.S., Elahi D. Loss of bone mineral density in women athletes during aging. Calcif. Tissue Int. 1998, 63:287-292.
166. Banfi G., Del Fabbro M., Lippi G. Relation between serum creatinine and body mass index in elite athletes of different sport disciplines. Br. J. Sports Med. 2006, 40:675-678.
167. Swaminathan R., Major P., Snieder H., Spector T. Serum creatinine and fat-free mass (lean body mass). Clin. Chem. 2000, 46:1695-1696.